苯并[b]噻吩-2-乙腈 | 75444-80-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻吩类
• 中文名称: 苯并[b]噻吩-2-乙腈
• 英文名称: benzothiophene-2-acetonitrile
• 英文别名: 2-(benzothiophen-2-yl)acetonitrile；2-cyanomethylbenzo[1,2-b]thiazole；benzo[b]thiophen-2-yl-acetonitrile；Benzo[b]thiophen-2-yl-acetonitril；benzo[b]thiophen-2-acetonitrile；2-(1-Benzothiophen-2-yl)acetonitrile
• CAS: 75444-80-3
• 化学式: C₁₀H₇NS
• 分子量: 173.238
• InChiKey: SPJJYCYYBXUZCP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  52
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  苯并[b]噻吩-2-乙腈 在 sodium hydroxide 作用下， 生成 苯并[b]噻吩-2-乙酸
  参考文献：
  名称：

  Derivatives of Thianaphthene. II

  摘要：

  DOI：

  10.1021/ja01176a079
• 作为产物：
  描述：

  苯并噻吩-2-羧酸 在 1,4-二氧六环 、 lithium aluminium tetrahydride 、 氯化亚砜 、 乙醚 作用下， 生成 苯并[b]噻吩-2-乙腈
  参考文献：
  名称：

  Derivatives of Thianaphthene. II

  摘要：

  DOI：

  10.1021/ja01176a079

文献信息

• [EN] AZETIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF METABOLIC AND INFLAMMATORY DISEASES<br/>[FR] DÉRIVÉS D'AZÉTIDINE UTILES POUR LE TRAITEMENT DE MALADIES MÉTABOLIQUES ET INFLAMMATOIRES
  申请人：GALAPAGOS NV

  公开号：WO2012098033A1

  公开（公告）日：2012-07-26

  Compounds are disclosed that have a formula represented by the following: These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example inflammatory conditions, infectious diseases, autoimmune diseases, diseases involving impairment of immune cell functions, cardiometabolic diseases, and/or proliferative diseases.

  披露了具有以下表示的公式的化合物：这些化合物可以制备为药物组合物，并可用于预防和治疗包括人类在内的哺乳动物的各种疾病，例如炎症性疾病、传染病、自身免疫疾病、涉及免疫细胞功能受损的疾病、心脏代谢疾病和/或增殖性疾病，举例不限。
• [EN] AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS<br/>[FR] DERIVES D'AZEPINOINDOLE ET DE PYRIDOINDOLE UTILISES COMME AGENTS PHARMACEUTIQUES
  申请人：X CEPTOR THERAPEUTICS INC

  公开号：WO2003099821A1

  公开（公告）日：2003-12-04

  The present invention is directed to compounds of formula (I) and formula (II): formula (I) and (II), wherein R1-R8, A and n are as described in the description. These compounds are used in pharmaceutical compositions and methods for modulating the activity of orphan nuclear receptors.

  本发明涉及化合物的公式（I）和公式（II）：公式（I）和（II），其中R1-R8，A和n如描述中所述。这些化合物用于制备药物组合物，并用于调节孤儿核受体的活性的方法。
• Rapid and Simple Access to α-(Hetero)arylacetonitriles from <i>Gem</i>-Difluoroalkenes
  作者：Jun-Qi Zhang、Jiayue Liu、Dandan Hu、Jinyu Song、Guorong Zhu、Hongjun Ren

  DOI：10.1021/acs.orglett.1c04336

  日期：2022.1.21

  A scalable cyanation of gem-difluoroalkenes to (hetero)arylacetonitrile derivatives was developed. This strategy features mild reaction conditions, excellent yields, wide substrate scope, and broad functional group tolerance. Significantly, in this reaction, aqueous ammonia offers a “N” source for the “CN” reagent and entirely avoids the use of toxic cyanating reagents or metal catalysis. Hence, we

  开发了一种可扩展的偕二氟烯烃氰化为（杂）芳基乙腈衍生物的方法。该策略具有反应条件温和、产率高、底物范围广、官能团耐受性广等特点。值得注意的是，在该反应中，氨水为“CN”试剂提供了“N”源，并且完全避免使用有毒的氰化试剂或金属催化剂。因此，我们为芳基乙腈的合成提供了一种绿色替代方法。
• Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
  申请人：Knoll Aktiengesellschaft

  公开号：US06187802B1

  公开（公告）日：2001-02-13

  Compounds of Formula I including pharmaceutically acceptable salts thereof in the form of individual enantiomers, racemates, or other mixtures of enantiomers, in which Ar is phenyl, naphthyl or benzo[b]thiophenyl, each of which may be optionally substituted; R1 and R2, which may be the same or different, independently are a) H, b) an alkyl group containing 1 to 6 carbon atoms, c) an alkenyl group containing 3 to 6 carbon atoms, d) a cycloalkyl group containing 3 to 7 carbon atoms, e) a cycloalkylmethyl group in which the ring contains 3 to 7 carbon atoms, f) an aryl or heteroaryl group optionally substituted g) an arylalkyl or heteroarylalkyl group each optionally substituted; or R1 and R2 form an alkylene chain optionally substituted by one or more alkyl groups each containing 1 to 3 carbon atoms, such that, together with the atoms to which they are attached, they form a 5 or 6 membered ring; R3 is a) H, b) an aryl or heteroaryl group each optionally substituted c) an optionally substituted arylmethyl group; or d) an alkoxyalkyl group containing 3 to 6 carbon atoms; and R4 and R5, which may be the same or different, independently are an alkyl group containing 1 to 3 carbon atoms, or R4 and R5 together with the atom to which they are attached form a cycloalkyl ring containing 3 to 6 carbon atoms; processes to prepare such compounds; compositions containing such compounds and their use in the treatment of depression, anxiety, Parkinson's disease, obesity, cognitive disorders, seizures, neurological disorders and as neuroprotective agents; are described.

  公式I的化合物包括其药用可接受盐的单体对映体、混合物或其他对映体混合物，其中Ar为苯基、萘基或苯并噻吩基，每种基可选择性地被取代；R1和R2，可能相同也可能不同，分别为a）H、b）含有1至6个碳原子的烷基基团、c）含有3至6个碳原子的烯基基团、d）含有3至7个碳原子的环烷基基团、e）环中含有3至7个碳原子的环烷基基团、f）可选择性取代的芳基或杂环芳基、g）可选择性取代的芳基烷基或杂环芳基烷基；或者R1和R2形成一个由1至3个碳原子的烷基基团选择性取代的烷基链，与它们连接的原子一起形成一个5或6元环；R3为a）H、b）可选择性取代的芳基或杂环芳基、c）可选择性取代的芳基甲基基团；或者d）含有3至6个碳原子的烷氧基烷基基团；而R4和R5，可能相同也可能不同，独立地为含有1至3个碳原子的烷基基团，或者R4和R5与它们连接的原子一起形成一个含有3至6个碳原子的环烷基环；描述了制备这种化合物的过程；含有这种化合物的组合物及其在治疗抑郁症、焦虑症、帕金森病、肥胖症、认知障碍、癫痫、神经系统疾病和作为神经保护剂中的用途。
• Nucleic acid components and their analogs: Design and synthesis of novel cytosine thioglycoside analogs
  作者：Galal H. Elgemeie、Ali M. Salah、Nermeen S. Abbas、Hoda A. Hussein、Reham A. Mohamed

  DOI：10.1080/15257770.2016.1231318

  日期：2017.2

  The synthesis of a new category of novel cytosine 4-thioglycoside analogs has been first accomplished. The main step of this strategy is the synthesis of sodium pyrimidine-4-thiolate through the condensation of 2-cyano-N-arylacetamides with sodium cyanocarbonimidodithioate, followed by coupling with α-bromo-sugars to afford the corresponding cytosine 4-thioglycoside analogs. The free thioglycosides

  新型胞嘧啶4-硫代糖苷类似物的新类别的合成已首先完成。该策略的主要步骤是通过2-氰基-N-芳基乙酰胺与氰基碳酰亚胺二硫代硫酸钠的缩合反应合成嘧啶-4-硫代硫酸钠，然后与α-溴糖偶联以提供相应的胞嘧啶4-硫代糖苷类似物。还制备了游离的硫代糖苷。随后报道了该策略在制备其他有效的嘧啶硫代糖苷中的应用的研究。